ABSTRACT
Objective To observe the short term effects of Rho-kinase inhibitor and Qiliqiangxin capsule on serum tumor necrosis factor-α(TNF-α)and interleukin-6(IL-6)levels in patients with chronic heart failure,and explore the mechanism.Methods 120 chronic heart failure patients received conventional treatment for 4 weeks were divided into blank control group(Group A,n=30),Rho-kinase inhibitor treated group(Group B,n=30), Qiliqiangxin capsules-treated group (Group C,n =30 ),and the other 30 cases were treated with Rho-kinase inhibitor combined with Qiliqiangxin capsules(GroupD,n=30).TNF-α,IL-6 and BNP were measured and cardiac function was evaluated before and after treatment.The difference between 4 groups was analyzed. Results After treatment,the levels of TNF-α,IL-6,BNP in the observation group were lower than that in the control group.The difference was statistically significant(P<0.05 ).The levels of TNF-α,IL-6,BNP in the D group were lower than that in the B and C group.The difference was statistically significant(P<0.05 ).Conclusion Rho-kinase inhibitor combined with Qiliqiangxin capsule can improve cardiac function and reduce levels of serum cytokines associated with chronic heart failure,which is conducive to the treatment of chronic heart failure.
ABSTRACT
The influenza A (H1N1) broke out in Mexico and the USA in March 2009, which soon spread over the world in coming months. This paper comprehensively analyzed the work of prevention and treatment to Influenza A (H1N1) by using traditional Chinese medicine in recent years, and briefly introduced the research of Influenza A (H1N1), specially summarized the possibility of using theory of TCM for predicting epidemic disease and the relationship between traditional Chinese medicine and influenza A (H1N1). Meanwhile some suggestions are made on the future work of prevention and treatment to Influenza A (H1N1) by using traditional Chinese medicine.